《港股》恆指半日升205點 阿里領漲 內房及金股上升
減息預期推動美股納指創新高,港股早市隨外圍上升,恆指高開77點後升幅擴大,曾升394點見26,027點,為近四年高位。半日升205點或0.8%,報25,839點;國指升82點或0.9%,報9,203點;恆生科技指數升59點或1%,報5,813點。大市半日成交總額1,596.77億元。
百度(09888.HK)擬發行44億人幣優先無擔保票據,該股平收報106.2元。中芯(00981.HK)擬每股74.2元人民幣發對價股收購中芯北方49%,中芯股價升1%。丘鈦科技(01478.HK)8月手機攝像頭模組銷量按年升40%,股價升1.3%。
國家藥監局就出台指南徵意見,規範處方藥網絡零售,醫療平台阿里健康(00241.HK)升6.6%,京東健康(06618.HK)及平安好醫生(01833.HK)升3%及1.5%。
其他科技股方面,阿里(09988.HK)升2.7%收141元,成交額126.58億元,快手(01024.HK)漲3.4%、京東(09618.HK)升2.9%,網易(09999.HK)揚3%,嗶哩嗶哩(09626.HK)升2.1%,騰訊(00700.HK)及小米(01810.HK)升1%及1.1%,美團(03690.HK)跌2.1%。新東方(09901.HK)升6.2%,地平線(09660.HK)、東方甄選(01797.HK)及藍思科技(06613.HK)跌2.3%至3.1%。
比亞迪及零跑部分車型列入新一批減免車輛購置稅目錄,比亞迪(01211.HK)平收報105.6元,零跑(09863.HK)升1.3%。據報小鵬(09868.HK)考慮明年在全球市場推出Mona品牌,小鵬升2.1%。蔚來(09866.HK)亦升2.1%。吉利(00175.HK)及理想(02015.HK)升3.8%及2.6%。醫藥股榮昌(09995.HK)及復星醫藥(02196.HK)升6.8%及4%,藥明生物(02269.HK)、康方(09926.HK)及藥明康德(02359.HK)跌2.5%至2.8%,金斯瑞(01548.HK)跌3.7%。
內房股顯著上升,世茂(00813.HK)升19.7%,合景泰富(01813.HK)及雅居樂(03383.HK)升14.9%及8.5%,金茂(00817.HK)、龍湖(00960.HK)、富力(02777.HK)、遠洋(03377.HK)及融創(01918.HK)升5%至6.8%,萬科(02202.HK)及潤地(01109.HK)升4.1%及4%,物管股華潤萬象(01209.HK)升5.6%。
金融股方面,匯控(00005.HK)及港交所(00388.HK)升0.2%及0.6%,友邦(01299.HK)升2%。金價持續破頂,山東黃金(01787.HK)、靈寶(03330.HK)及中國黃金國際(02099.HK)升6.6%至7.9%,招金(01818.HK)及紫金(02899.HK)升3.2%及2.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.